PHARMASEAL International has announced that it will offer the Engility CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The offer is open to biopharmaceutical organizations and academic institutions.

For more information, click here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!